雷米马佐拉姆在预防术后恶心和吐方面的有效性:系统性审查和元分析
Hyun-Su Ri1, Soeun Jeon2, Jinseok Yeo1,3
1Department of Anesthesia and Pain Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
雷米马佐拉姆在预防术后恶心和吐 (PONV) 方面与其他麻醉剂没有显著差异. 然而,它比吸入麻醉剂更有效,但在PONV预防方面效果不如普罗波.
科学领域:
- 麻醉学 麻醉学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 手术后恶心和吐 (PONV) 是麻醉后的一个常见并发症.
- 雷米马佐拉姆是一种新型的,超短作用的静脉注射麻醉剂.
- 对临床实践来说,评估雷马佐拉姆在PONV预防中的有效性至关重要.
研究的目的:
- 进行一项元分析,比较雷米马佐拉姆与其他麻醉剂在预防PONV方面的疗效.
- 评估雷马佐拉姆在PONV预防方面的整体和亚组疗效.
主要方法:
- 在PubMed,Cochrane图书馆和Embase的系统文献搜索到2024年1月.
- 包括随机对照试验 (RCT),将雷米马佐拉姆与其他麻醉剂进行比较.
- 使用相对风险 (RR) 和95%置信区间 (95% CI) 的数据合成,并进行子组分析.
主要成果:
- 分析包括50个RCT与9,193名参与者.
- 雷米马佐拉姆与其他麻醉剂之间的整体PONV发病率没有显著差异 (RR:0.96,95%CI:0.80-1.13).
- 亚组分析:雷米马佐拉姆的PONV发病率低于吸入麻醉剂 (RR:0.50,95%CI:0.34-0.73),但吐发病率高于普罗波 (RR:1.41,95%CI:1.05-1.90).
结论:
- 与其他麻醉剂相比,雷米马佐拉姆在PONV预防方面没有显著的整体差异.
- 雷米马佐拉姆在缓解PONV方面比吸入麻醉剂更有效.
- 雷米马佐拉姆在预防术后吐方面效果不如普罗波.
更多相关视频
08:49Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
Published on: October 16, 2013
14:52Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers
Published on: January 13, 2018
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Parenteral Anesthetics: Overview
